AZRX News and Press, AzurRx BioPharma Inc. From 07/16/21

NEW YORK, July 16, 2021 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street / Newsmax TV announces its TV airing of this weeks’, Sunday, July 18, 2021, broadcasting line-up of its national syndicated 1- hour show, 10-11AM ET. New to The Street’s ...

BOCA RATON, Fla., June 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestin...

AzurRx BioPharma (AZRX) announces that it has dosed the first patient in a phase 2 clinical trial of niclosamide for the treatment of COVID-19 gastrointestinal infections.FW-1022, which is a proprietary oral tablet formulation of micronized niclosamide developed for the treatment of COVI...

“RESERVOIR” trial to evaluate niclosamide’s ability to target SARS-CoV-2 in the GI tract Topline trial data expected in Q1 2022 BOCA RATON, Fla., June 07, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or t...

NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) -- FMW Media’s “ New to The Street” TV broadcasting its national syndicated 1- hour show, Sunday, June 06, 2021 on NEWSMAX TV from 10-11AM ET. “New To The Street’s” TV Sunday line-up...

NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) -- FMW Media’s “ New to The Street” TV broadcasting its national syndicated 1- hour show, Sunday, May 16, 2021 on NEWSMAX TV from 10-11AM ET. “New To The Street’s” TV Sunday line-up ...

DELRAY BEACH, Fla., May 19, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) d...

NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- FMW Media’s “ New to The Street” TV broadcasting its national syndicated 1- hour show, Sunday, May 16, 2021 on NEWSMAX TV from 10-11AM ET. “New To The Street’s” “BIG”...

NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- FMW Media Corp. announces that its “New To The Street” business TV show will feature AzurRx BioPharma, Inc. (NASDAQ: AZRX) in a 3-part TV series featured across its entire syndicated linear television platform. The televised int...

AzurRx BioPharma (AZRX) said that its experimental therapy MS1819 led to clinically meaningful improvements in the primary efficacy endpoint in a Phase 2 trial for the treatment of severe exocrine pancreatic insufficiency ((EPI)) in patients with cystic fibrosis ((CF)). The multi-center study...